PortfoliosLab logo

Aerie Pharmaceuticals, Inc. (AERI)

Equity · Currency in USD
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
ISIN
US00771V1089
CUSIP
00771V108

AERIPrice Chart


Chart placeholderClick Calculate to get results

AERIPerformance

The chart shows the growth of $10,000 invested in Aerie Pharmaceuticals, Inc. on Oct 28, 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $6,343 for a total return of roughly -36.57%. All prices are adjusted for splits and dividends.


AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (S&P 500)

AERIReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD-4.13%-7.73%
1M-15.98%-5.40%
6M-56.66%0.70%
1Y-57.83%14.18%
5Y-30.21%14.13%
10Y-5.38%11.77%

AERIMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

AERISharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aerie Pharmaceuticals, Inc. Sharpe ratio is -0.85. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (S&P 500)

AERIDividends


Aerie Pharmaceuticals, Inc. doesn't pay dividends

AERIDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (S&P 500)

AERIWorst Drawdowns

The table below shows the maximum drawdowns of the Aerie Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aerie Pharmaceuticals, Inc. is 90.89%, recorded on Jan 21, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.89%Jul 20, 2018884Jan 21, 2022
-73.52%Apr 24, 20156May 1, 2015350Sep 20, 2016356
-44.78%Mar 5, 201446May 8, 201433Jun 25, 201479
-39.55%Jun 27, 201429Aug 7, 201477Nov 25, 2014106
-26.56%Jan 16, 20148Jan 28, 201421Feb 27, 201429
-26.5%Oct 23, 2017138May 10, 201819Jun 7, 2018157
-23.32%Mar 8, 201750May 17, 20176May 25, 201756
-21.5%Jan 5, 201523Feb 5, 201530Mar 20, 201553
-19.82%Oct 11, 201619Nov 4, 20167Nov 15, 201626
-19.13%Sep 19, 20179Sep 29, 20178Oct 11, 201717

AERIVolatility Chart

Current Aerie Pharmaceuticals, Inc. volatility is 74.23%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (S&P 500)

Portfolios with Aerie Pharmaceuticals, Inc.


Loading data...

More Tools for Aerie Pharmaceuticals, Inc.